Frazier Management is an investment fund managing more than $1.12 million ran by Steve Bailey. There is currently 1 company in Mr. Bailey’s portfolio. The largest and only investment include Sierra Oncology Inc worth $1.12 million.
As of 3rd August 2022, Frazier Management’s top holding is 20,316 shares of Sierra Oncology Inc currently worth over $1.12 million and making up 100.0% of the portfolio value.
Relative to the number of outstanding shares of Sierra Oncology Inc, Frazier Management owns more than approximately 0.1% of the company.
Currently, Frazier Management's portfolio is worth at least $1.12 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Frazier Management office and employees reside in Seattle, Washington. According to the last 13-F report filed with the SEC, Steve Bailey serves as the CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER at Frazier Management.
There are companies that Frazier Management is getting rid of from its portfolio.
Frazier Management closed its position in Allena Pharmaceuticals Inc on 10th August 2022.
It sold the previously owned 1,019,288 shares for $236 thousand.
Steve Bailey also disclosed a decreased stake in Sierra Oncology Inc by 0.6%.
This leaves the value of the investment at $1.12 million and 20,316 shares.
The two most similar investment funds to Frazier Management are Tang Kevin C and Allied Irish Banks PLC. They manage $1.12 million and $1.13 million respectively.
Frazier Management’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $828 million.
These positions were updated on August 10th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Sierra Oncology Inc |
62.83%
20,316
|
$1,117,000 | 100.00% |
| Allena Pharmaceuticals Inc |
Closed
1,019,288
|
$236,000 | |
| No transactions found | |||
| Showing first 500 out of 2 holdings | |||